179 related articles for article (PubMed ID: 20616686)
41. Microperimetric changes after intravitreal triamcinolone acetonide injection for macular edema due to central retinal vein occlusion.
Senturk F; Ozdemir H; Karacorlu M; Karacorlu SA; Uysal O
Retina; 2010 Sep; 30(8):1254-61. PubMed ID: 20827142
[TBL] [Abstract][Full Text] [Related]
42. Course of macular edema in uveitis under medical treatment.
Markomichelakis NN; Halkiadakis I; Pantelia E; Georgalas I; Chrysanthi K; Theodossiadis P; Moschos M; Theodossiadis G; Kouvatseas G
Ocul Immunol Inflamm; 2007; 15(2):71-9. PubMed ID: 17558831
[TBL] [Abstract][Full Text] [Related]
43. Long-term outcome of an intravitreal dexamethasone implant for the treatment of noninfectious uveitic macular edema.
Habot-Wilner Z; Sorkin N; Goldenberg D; Loewenstein A; Goldstein M
Ophthalmologica; 2014; 232(2):77-82. PubMed ID: 25012541
[TBL] [Abstract][Full Text] [Related]
44. Incidence of postvitrectomy macular edema using optical coherence tomography.
Kim SJ; Martin DF; Hubbard GB; Srivastava SK; Yan J; Bergstrom CS; Aaberg TM
Ophthalmology; 2009 Aug; 116(8):1531-7. PubMed ID: 19501405
[TBL] [Abstract][Full Text] [Related]
45. The transient efficacy of a single intravitreal triamcinolone acetonide injection for diabetic macular edema.
Desatnik H; Habot-Wilner Z; Alhalel A; Moroz I; Glovinsky J; Moisseiev J
Isr Med Assoc J; 2006 Jun; 8(6):383-7. PubMed ID: 16833165
[TBL] [Abstract][Full Text] [Related]
46. Intravitreal dexamethasone implant in patients with persistent macular edema of variable etiologies.
Sorkin N; Loewenstein A; Habot-Wilner Z; Goldstein M
Ophthalmologica; 2014; 232(2):83-91. PubMed ID: 24942067
[TBL] [Abstract][Full Text] [Related]
47. Intravitreal triamcinolone acetonide for patients with macular edema due to branch retinal vein occlusion.
Cheng KC; Wu WC
Kaohsiung J Med Sci; 2006 Jul; 22(7):321-30. PubMed ID: 16849100
[TBL] [Abstract][Full Text] [Related]
48. Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion.
Hayashi K; Hayashi H
Am J Ophthalmol; 2005 Jun; 139(6):972-82. PubMed ID: 15953425
[TBL] [Abstract][Full Text] [Related]
49. [Multicenter Ozurdex® assessment for diabetic macular edema: MOZART study].
Guigou S; Hajjar C; Parrat E; Merite PY; Pommier S; Matonti F; Prost-Magnin O; Meyer F
J Fr Ophtalmol; 2014 Jun; 37(6):480-5. PubMed ID: 24813119
[TBL] [Abstract][Full Text] [Related]
50. Efficacy and Safety of Intravitreal Dexamethasone Implant in Patients with Diabetic Macular Edema.
Guigou S; Pommier S; Meyer F; Hajjar C; Merite PY; Parrat E; Rouhette H; Rebollo O; Matonti F
Ophthalmologica; 2015; 233(3-4):169-75. PubMed ID: 25924737
[TBL] [Abstract][Full Text] [Related]
51. Dexamethasone intravitreal implant for treatment of patients with persistent diabetic macular edema.
Dutra Medeiros M; Postorino M; Navarro R; Garcia-Arumí J; Mateo C; Corcóstegui B
Ophthalmologica; 2014; 231(3):141-6. PubMed ID: 24356099
[TBL] [Abstract][Full Text] [Related]
52. The effect of an intravitreal dexamethasone implant for cystoid macular edema in retinitis pigmentosa: a case report and literature review.
Ahn SJ; Kim KE; Woo SJ; Park KH
Ophthalmic Surg Lasers Imaging Retina; 2014; 45(2):160-4. PubMed ID: 24506098
[TBL] [Abstract][Full Text] [Related]
53. Qualitative and Quantitative Assessment of Vascular Changes in Diabetic Macular Edema after Dexamethasone Implant Using Optical Coherence Tomography Angiography.
Toto L; D'Aloisio R; Di Nicola M; Di Martino G; Di Staso S; Ciancaglini M; Tognetto D; Mastropasqua L
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28574436
[TBL] [Abstract][Full Text] [Related]
54. Effect of aging on macular features of X-linked retinoschisis assessed with optical coherence tomography.
Menke MN; Feke GT; Hirose T
Retina; 2011 Jun; 31(6):1186-92. PubMed ID: 21386765
[TBL] [Abstract][Full Text] [Related]
55. Bilateral effect of unilateral dexamethasone intravitreal implant in a case of noninfectious uveitic macular edema and vitritis.
Habot-Wilner Z; Sorkin N; Goldenberg D; Goldstein M
Retin Cases Brief Rep; 2015; 9(2):151-3. PubMed ID: 25462131
[TBL] [Abstract][Full Text] [Related]
56. Vitreous pillow for sustained-release intravitreous drug delivery implants.
Kapoor KG; Shultz RW; Iezzi R
Ophthalmic Surg Lasers Imaging Retina; 2013; 44(2):181-2. PubMed ID: 23510043
[TBL] [Abstract][Full Text] [Related]
57. Association between the macular volume and visual acuity was found to be weak.
Chhablani JK; Bartsch DU; Freeman W
Retina; 2011 Apr; 31(4):815; author reply 815-6. PubMed ID: 21394056
[No Abstract] [Full Text] [Related]
58. Treatment of postoperative cystoid macular oedema with dexamethasone intravitreal implant in a vitrectomized eye -- a case report.
Merkoudis N; Granstam E
Acta Ophthalmol; 2013 May; 91(3):e238-9. PubMed ID: 23164050
[No Abstract] [Full Text] [Related]
59. Dexamethasone intravitreal implant during phacoemulsification.
Agarwal A; Gupta V; Ram J; Gupta A
Ophthalmology; 2013 Jan; 120(1):211, 211.e1-5. PubMed ID: 23283186
[No Abstract] [Full Text] [Related]
60. Identifying a clinically meaningful threshold for change in uveitic macular edema evaluated by optical coherence tomography.
Sugar EA; Jabs DA; Altaweel MM; Lightman S; Acharya N; Vitale AT; Thorne JE;
Am J Ophthalmol; 2011 Dec; 152(6):1044-1052.e5. PubMed ID: 21861971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
